TAFIa inhibitors (Sanofi)

N/A

Report date: 2025/03/19 11:40:43
NME

Base Information

Drug NameTAFIa inhibitors (Sanofi)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarboxypeptidase B2 isoform A inhibitorsCoagulation factor inhibitors
TargetsCarboxypeptidase B2 isoform ACoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A